biote Corp. (BTMD) stock
BTMDNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/3069% below fair value
$0.99+0.03 (+3.09%)
Close on Nov 17, 2026Market cap $35.57MP/E 9.9Yield –
biote price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
biote's price to sales ratio was 0.2× on Nov 11, 2026, against 0.5× a year earlier. Over the last 4 years it ranged from 0.2× to 2.3×, with a median of 0.6×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.2× | −0.3 |
| 2025 | Dec 31, 2025 | 0.5× | −0.6 |
| 2024 | Dec 31, 2024 | 1.1× | +0.5 |
| 2023 | Dec 29, 2023 | 0.5× | −0.8 |
| 2022 | Dec 30, 2022 | 1.3× | – |
See a number that looks wrong?